PRISM Regulatory Modernization Cooperative Agreement

FDA announced the Pathways for Regulatory Innovation and Strategic Modernization (PRISM) cooperative agreement funding opportunity of up to $1.3 million. Applications close April 30, 2026. Only the Reagan-Udall Foundation for the FDA is eligible to apply under this single-source award (RFA-FD-26-007).

Romania State Aid Battery Storage - Commission No Objections

The European Commission authorized Romania's state aid measure SA.121308 for battery storage projects under Articles 107 and 108 TFEU. The Commission raised no objections to the aid, finding it compatible with the internal market. This decision allows Romania to provide support to battery storage facilities without initiating the formal investigation procedure.

French SME Rescue/Restructuring State Aid Authorized

The European Commission authorized French SME rescue and restructuring State aid under Articles 107 and 108 TFEU. Case SA.122002 was approved with the Commission raising no objections. The decision is published in Official Journal C/2026/2062.

Euro Exchange Rates

The European Central Bank published official euro exchange rates as of 31 March 2026 in Official Journal C/2026/1107. The rates are published for informational purposes and provide reference exchange rates for EU and international transactions. No compliance actions or deadlines are associated with this routine publication.

EFSA Networking Organisations Notice

The European Food Safety Authority published Notice C/2026/1982 in Official Journal C-series on 1 April 2026 regarding networking of organisations operating within EFSA's mission. The notice provides information about how organisations collaborate with EFSA in food safety domains. This is an administrative notice without binding requirements or compliance obligations.

Diplomatic Mission Specimen Card Updates Under Schengen Borders Code

The European Commission published an Official Journal notice (C/2026/2063) updating specimen cards issued by EU Member State foreign ministries to accredited diplomatic mission members, consular representatives, and their families under Article 20(2) of Regulation (EU) 2016/399 (Schengen Borders Code). The notice serves as an administrative update to existing specimen card formats used for border crossing documentation of diplomatic personnel.

SIRIUS/BROOKFIELD/PARADISE JV Merger Notification

The European Commission published notice of prior notification for Case M.12345 – SIRIUS / BROOKFIELD / PARADISE JV in the Official Journal. The transaction has been identified as a candidate for the simplified merger review procedure. This notice informs market participants of the proposed concentration and initiates the statutory review period under EU merger control regulations.

Prior notification of a concentration (Case M.12389 – GIM / TCR)

The European Commission published a prior notification of concentration Case M.12389 involving GIM and TCR in the Official Journal. The transaction is a candidate for the simplified merger control procedure, indicating it meets criteria for streamlined review. Third parties may submit observations on the proposed concentration.

ADVENT/AFK/TA/VOLUE Merger Notification - Simplified Procedure

The European Commission published prior notification of concentration Case M.12386 involving ADVENT, AFK, TA, and VOLUE in the Official Journal C series. The notification was published on April 1, 2026 (ELI: http://data.europa.eu/eli/C/2026/2056/oj) under publication number PUB/2026/380. The case has been designated as a candidate for the simplified merger review procedure, indicating the Commission views it as unlikely to raise competition concerns.

BCI/Brookfield/NBIM Joint Venture Concentration Notification

The European Commission published a prior notification of a concentration (Case M.12346) involving BCI, Brookfield, NBIM, and Mustang AIV JV. The notification, published on April 1, 2026, has been designated as a candidate for the simplified procedure under the EU Merger Regulation. This indicates the Commission considers the transaction unlikely to raise competition concerns given its nature or limited market impact.